Endocrine aspects of anabolic steroids

Clinical Chemistry

Volumn 43, Issue 7, 1997, Pages 1289-1292

  Wu, F C W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Abused drugs; Androgen receptor; Sports medicine

Indexed keywords

ANABOLIC AGENT; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; TESTOSTERONE;

CONFERENCE PAPER; DOSE RESPONSE; DRUG MECHANISM; HORMONAL THERAPY; INCIDENCE; LONG TERM CARE; MUSCLE MASS; MUSCLE STRENGTH; RISK ASSESSMENT;

EID: 0030851537     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.7.1289     Document Type: Conference Paper

References (17)

1. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 1993;76:17-23.
2. Quigley CA, De Bellis A, Marschke KB, El-Alwardy MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-95.
3. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-61.
4. Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 1993: 14:577-93.
5. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-98.
6. Wilson JD. Androgen abuse by athletes. Endocr Rev 1988;9:181-99.
7. Elashoff JD, Jacknow AD, Shain SG, Braunstein GD. Effects of androgenic-anabolic steroid on muscle strength. Ann Intern Med 1991;115:387-93.
8. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 1996;335: 1-7.
9. Rance NE, Max SR. Modulation of the cytosolic androgen receptor in striated muscle by sex steroids. Endocrinology 1984;115: 862-6.
10. Wilson JD, Gloyna E. The intranuclear metabolism of testosterone in the accessory organs of male reproduction. Rec Prog Horm Res 1970;26:309-36.
11. Bartsch W, Krieg M, Voigt KD. Regulation and compartmentalization of androgens in the rat prostate and muscle. J Steroid Biochem 1983;19:929-37.
12. Hickson RC, Czerwinski SM, Falduto MT, Young AP. Glucocorticoid antagonism by exercise and androgenic-anabolic steroids. Med Sci Sports Exerc 1990;22:331-40.
13. Tincello DG, Saunders PTK, Hodgins MB, Simpson NB, Edwards CRW, Hargreave TB, Wu FCW. Partial androgen insensitivity and Reifenstein's syndrome: clinical, endocrine and molecular correlates and in vivo response to high-dose testosterone. J Endocrinol 1997;in press.
14. Celotti F, Negri Cesi P. Anabolic steroids: a review of their effects on the muscles, of their possible mechanisms of actions and of their use in athletics. J Steroid Biochem Mol Biol 1992;43:469-77.
15. Rogol AD, Yesalis CE III. Anabolic-androgenic steroids and athletes: what are the issues? J Clin Endocrinol Metab 1992;74: 465-9.
16. Wallace EM, Pye SD, Wild SR, Wu FCW. Prostate specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception. Int J Androl 1993;16:35-40.
17. Pope HG, Katz DL. Psychiatric effects of anabolic steroids. Psychiatr Ann 1992;22:24-9.